±±Ê¦´óϸ°ûÉúÎïѧ£¨ÀúÄêÊÔÌâ×ܽᣩ n N<N~
Ò»¡¢ Ãû´Ê½âÊÍ£º ?gE=hh
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© ;}46Uc#WS
2£® PCR£¨96£© 9jkz83/+<
3£® ·ºËØ£¨ubquitin£©£¨96£© aDbqh~7
4£® °é·Ö×Ó£¨chapron£©£¨96£© OpU
fK4U)
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© 0WUBj:@g
6£® DG£IP3£¨96£© !Z!)$3
bB
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© d9f7 &
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© <>] DcA
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© H
bKE;N
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© N"S`9B1eD(
11£® Transformation£¨92£© %6m/ve
12£® TransfectionתȾ£¨92£© PF{uaKWk
13£® Transcytosis×ªÒÆ×÷Óã¨92£©
=z.j{%
14£® Transductionתµ¼£¨92£© -/Q5?0z
15£® Transdetermination£¨92£© 11H`WOTQF
16£® Transdifferentiation£¨92£© c+:ZmrP/
17£® Transgenic animalת»ùÒò¶¯Î92£© .hT>a<
18£® Rb£1£¨92£© \((iR>^|
19£® P53£¨92¡¢91£© mxv?PP
20£® C£jun£¨92£© ='7m$,{(Q[
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© HsCL%$k
22£® °ûÄÚÌ壨99£© _jQ:9,;
A
23£® Cyclin dependent kinase inhibitor(CDKI)(99) wLV,E,gM
24£® G£protein£¨91£© B>2=IZ
25£® Restriction point£¨91£© */aY$a
Wv
26£® Antipost£¨91£© -KiPqE%&G
27£® Capping£¨91£© fv;Q*; oC&
28£® TATAbox£¨91£©
c1H.v^Y5
29£® cDNA library£¨90£© aHhLz>H'
30£® Aritotic apparatus£¨90£© JX59n%$@
31£® ¿çĤÐźŠtransmembrane signal£¨90£© )UR$VL
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© e{)giJY9
33£® Nuclear lamina£¨90£© aBAoSn
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© !wYN",R-
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© E>fY,*0
36£® ϸ°û·Ö»¯£¨00£© 9ihg[k
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© Gs:g
38£® ¿Ë¡£¨00£© xQ9t1b|{e
39£® »ùÒò×飨00£© s< tG
40£® Caspase£¨00£© Kw fd
S(
41£® ת¼Òò×Ó£¨00£© EjPR+m
42£® ÅßÌ¥¸Éϸ°û£¨01£© 8lk/*/} =<
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© g@H<Q('fJ
44£® DNAоƬ£¨01£© Y.m1d ?H 1
¶þ¡¢ ÎÊ´ðÌ⣺ [}L?EM
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© cW3'057
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© 49FP&NgK
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© '/GB8L
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© 5<Kt"5Z%7
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© tB;PGk_6
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© (?Ku-k
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© W6?=9].gc
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© FBE|pG7
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© eC/{c1C
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© /KH85/s
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© C:1(<1K
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© L,zx\cj?z
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© L|[i<s;
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© w5Fk#zJv
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£©
Gs#9'3_U5
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© Rk9n,"xpv
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© \d:Q%S
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£©
R &1>
\t
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© Y6wr}U
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© [O
r1
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© GUL~k@:_k
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© J_F\cM
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© #>yOp *
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© g_4%M0&AX
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© .i\FK@2
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© )
`{jPK*`
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© pg5W`4-F
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© rk=/iD
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© WG,
Il/
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© gZHgL7@
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© B\D)21Ik}%
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© i:Y5aZc/Ds
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© |i
B#
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© y ;mk]
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©